Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
July 24, 2018
EDAP TMS SA to Announce Second Quarter 2018 Financial Results on Thursday, August 30
LYON, France, July 24, 2018 - EDAP TMS SA (EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results ...
July 24, 2018
Aptose To Release Second Quarter Ended June 30, 2018 Financial Results and Hold Conference Call on August 7, 2018
SAN DIEGO and TORONTO, July 24, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (APTO) (APS.TO), a clinical-stage company developing highly differentiated therapeutics targeting the underlying ...
July 24, 2018
Arrowhead Pharmaceuticals to Webcast Fiscal 2018 Third Quarter Results
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (ARWR) today announced that it will host a webcast and conference call on August 7, 2018, at 4:30 p.m. EDT ...
July 24, 2018
Allakos Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
SAN CARLOS, Calif., July 24, 2018 (GLOBE NEWSWIRE) -- Allakos Inc. (ALLK), a clinical stage biotechnology company focused on the development of antibodies for the ...
July 24, 2018
HTG Molecular Diagnostics to Announce Second Quarter and Six Months Ended June 30, 2018 Financial Results and Host Conference Call on Tuesday, August 7
TUCSON, Ariz., July 24, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today ...
July 24, 2018
scPharmaceuticals Announces Appointment of Two New Directors
BURLINGTON, Mass., July 24, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to ...
July 24, 2018
Achaogen to Host Conference Call and Webcast of Second Quarter 2018 Financial Results on August 6, 2018
SOUTH SAN FRANCISCO, Calif., July 24, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a biopharmaceutical company developing and commercializing innovative antibacterial agents to address multi-drug ...
July 24, 2018
RedHill Biopharma Enrolls 400th Patient in Confirmatory Phase III Study with TALICIA® for H. pylori Infection
TEL-AVIV, Israel and RALEIGH, N.C., July 24, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical ...
July 23, 2018
Reata Announces Positive Phase 2 Data for Bardoxolone Methyl in CKD Caused by Alport Syndrome and Autosomal Dominant Polycystic Kidney Disease
IRVING, Texas, July 23, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (RETA), a clinical-stage biopharmaceutical company, today announced results from two Phase 2 studies of ...
July 23, 2018
Arcturus Therapeutics Achieves Program Milestones and Refines Agreement with Cystic Fibrosis Foundation Therapeutics
SAN DIEGO, July 23, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (ARCT), a leading RNA medicines company, today announced the achievement of key milestones as ...
July 23, 2018
BioTime to Announce Second Quarter 2018 Results on August 2, 2018
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that it will release second quarter 2018 financial ...
July 23, 2018
RedHill Biopharma Announces Uplisting to Nasdaq Global Market
TEL-AVIV, Israel and RALEIGH, N.C., July 23, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical ...
July 23, 2018
Paratek Pharmaceuticals to Report Second Quarter 2018 Financial Results on August 2, 2018
BOSTON, July 23, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon ...
July 23, 2018
STRATA Skin Sciences Announces Licensing Agreement for Certain MelaFind Assets
HORSHAM, Pa., July 23, 2018 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, ...
July 23, 2018
BrainStorm Announces Financial Results for the Second Quarter of 2018 and Provides a Corporate Update
NEW YORK and PETACH TIKVAH, Israel, July 23, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell technologies for neurodegenerative ...
July 20, 2018
PureTech Health Announces Collaboration with Roche to Advance Technology for Oral Administration of Antisense Oligonucleotides
BOSTON--(BUSINESS WIRE)-- PureTech Health to receive up to $36 million in upfront payments, research support, and early preclinical milestones and is eligible to potentially receive ...
July 20, 2018
Achaogen Launches ZEMDRI™ (plazomicin), a Once-Daily Aminoglycoside for use in complicated Urinary Tract Infections (cUTI)
SOUTH SAN FRANCISCO, Calif., July 20, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a biopharmaceutical company developing and commercializing innovative antibacterial agents to address multi-drug ...
July 19, 2018
Aeglea BioTherapeutics Appoints Dr. Anthony G. Quinn as President and Chief Executive Officer
AUSTIN, Texas, July 19, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for ...
July 19, 2018
Inventiva Reports First-half 2018 Financial Results and Provides a Corporate Update
Cash position at €75.9 million as of June 30, 2018 Successful €32.5 million private placement on April 17, 2018 (net proceeds) strengthening the company`s cash ...
July 19, 2018
ArQule to Report Second Quarter 2018 Financial Results on August 1, 2018
BURLINGTON, Mass.--(BUSINESS WIRE)--ArQule, Inc. (ARQL) today announced it will report financial results for the second quarter of 2018 before the market opens on Wednesday, August ...
Page 26 of 117